FDA declines to approve lung cancer drug | The Hill: Healthcare Policy

admin March 24, 2022

U.S. pharmaceutical company Eli Lilly announced on Thursday that the Food and Drug Administration declined approving its application for approval of a new cancer drug meant to treat nonsquamous non-small cell lung cancer....